1 |
Tobacco smoking and its drug interactions with comedications involving CYP and UGT enzymes and nicotine
Naina Mohamed Pakkir Maideen
World J Pharmacol
8(2):14-25.
Published online Jan 30, 2019.
doi: 10.5497/wjp.v8.i2.14
|
2 |
Ocular drug delivery systems: An overview
Ashaben Patel, Kishore Cholkar, Vibhuti Agrahari, Ashim K Mitra
World J Pharmacol
2(2):47-64.
Published online Jun 9, 2013.
doi: 10.5497/wjp.v2.i2.47
|
3 |
Role of mitogen- and stress-activated kinases in inflammatory arthritis
Sylvain G Bourgoin, Weili Hui
World J Pharmacol
4(4):265-273.
Published online Dec 9, 2015.
doi: 10.5497/wjp.v4.i4.265
|
4 |
Drug delivery in ocular diseases: Barriers and strategies
Deep Kwatra, Ashim K Mitra
World J Pharmacol
2(4):78-83.
Published online Dec 9, 2013.
doi: 10.5497/wjp.v2.i4.78
|
5 |
Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?
Pamela J Weathers, Melissa Towler, Ahmed Hassanali, Pierre Lutgen, Patrick Ogwang Engeu
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
|
6 |
Therapeutic targets and delivery challenges for Alzheimer’s disease
Preshita Desai, Harshad Shete, Rahul Adnaik, John Disouza, Vandana Patravale
World J Pharmacol
4(3):236-264.
Published online Sep 9, 2015.
doi: 10.5497/wjp.v4.i3.236
|
7 |
Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome
Asfandyar Khan, Adam B Murphy
World J Pharmacol
4(1):1-16.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.1
|
8 |
Novel strategies for the treatment of diabetic macular edema
Hoang M Trinh, Mary Joseph, Kishore Cholkar, Dhananjay Pal, Ashim K Mitra
World J Pharmacol
5(1):1-14.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.1
|
9 |
Non-selective beta-blockers in cirrhosis: Current concepts and controversies
Neil Rajoriya, Dhiraj Tripathi
World J Pharmacol
5(1):15-31.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.15
|
10 |
Tenofovir induced severe thrombocytopenia
Mayank Jain, Joy Vargese, Jayanthi Venkatatraman
World J Pharmacology
6(2):11-13.
Published online Jun 9, 2017.
doi: 10.5497/wjp.v6.i2.11
|
11 |
How and why chemicals from tobacco smoke can induce a rise in blood pressure
World J Pharmacol
1(1):10-20.
Published online Feb 9, 2012.
doi: 10.5497/wjp.v1.i1.10
|
12 |
Appropriate prescribing in the elderly: Current perspectives
Amanda Hanora Lavan, John O’Grady, Paul Francis Gallagher
World J Pharmacol
4(2):193-209.
Published online Jun 9, 2015.
doi: 10.5497/wjp.v4.i2.193
|
13 |
Emerging pharmacological strategies for the treatment of fibromyalgia
World J Pharmacology
6(1):1-10.
Published online Mar 9, 2017.
doi: 10.5497/wjp.v6.i1.1
|
14 |
Adalimumab and pharmacokinetics: Impact on the clinical prescription for inflammatory bowel disease
Anne-Laure Pelletier, Pascale Nicaise-Roland
World J Pharmacol
5(1):44-50.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.44
|
15 |
Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis
World J Pharmacology
7(1):1-9.
Published online Oct 22, 2018.
doi: 10.5497/wjp.v7.i1.1
|
16 |
Pharmacology and clinical applications of flupirtine: Current and future options
World J Pharmacology
8(1):1-13.
Published online Jan 15, 2019.
doi: 10.5497/wjp.v8.i1.1
|
17 |
Bacterial biofilms in human gastrointestinal tract: An intricate balance between health and inflammatory bowel diseases
Niharika Chandra, Ankita Srivastava, Sunil Kumar
World J Pharmacol
8(3):26-40.
Published online Aug 28, 2019.
doi: 10.5497/wjp.v8.i3.26
|
18 |
Drug-transporter interaction testing in drug discovery and development
World J Pharmacol
2(1):35-46.
Published online Mar 9, 2013.
doi: 10.5497/wjp.v2.i1.35
|
19 |
Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?
Serena Mazzucchelli, Marta Truffi, Luisa Fiandra, Luca Sorrentino, Fabio Corsi
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
|
20 |
Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer
Juliana Felgueiras, Margarida Fardilha
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
|
21 |
Carbapenemases: A worldwide threat to antimicrobial therapy
José Miguel Sahuquillo-Arce, Alicia Hernández-Cabezas, Fernanda Yarad-Auad, Elisa Ibáñez-Martínez, Patricia Falomir-Salcedo, Alba Ruiz-Gaitán
World J Pharmacol
4(1):75-95.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.75
|
22 |
Allosteric modulation of cholinergic system: Potential approach to treating cognitive deficits of schizophrenia
Shaun Hopper, Madhara Udawela, Elizabeth Scarr, Brian Dean
World J Pharmacol
5(1):32-43.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.32
|
23 |
Innovate combination of sevoflurane dilution in dimethyl sulfoxide: A stability study by gas chromatography and nuclear magnetic resonance
F Dámaso Fernández-Ginés, Sergio García-Muñoz, Héctor Mateo-Carrasco, Miguel Ángel Rincón-Cervera, Manuel Cortiñas-Sáenz, José Antonio Morales-Molina, Carmen Fernández-Sánchez, Juan Miguel Expósito-López, Ignacio Rodríguez-García
World J Pharmacology
5(3):59-67.
Published online Sep 9, 2016.
doi: 10.5497/wjp.v5.i3.59
|
24 |
Chemoprevention of gastrointestinal cancers by natural honey
World J Pharmacol
4(1):160-167.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.160
|
25 |
Asthma in pregnancy
Hayley K Blackburn, Douglas R Allington, Kendra A Procacci, Michael P Rivey
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
|
26 |
Role of opioid receptor heterodimerization in pain modulation and tolerance development
Annu Mudgal, Santosh Pasha
World J Pharmacol
4(1):144-159.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.144
|
27 |
Pharmacophore approaches in protein kinase inhibitors design
Sergiy A Starosyla, Galyna P Volynets, Volodymyr G Bdzhola, Andriy G Golub, Sergiy M Yarmoluk
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
|
28 |
Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement
María L Cuestas, José R Oubiña, Verónica L Mathet
World J Pharmacol
4(1):96-116.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.96
|
29 |
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
Mohamed S Anwar, John F Dillon, Michael H Miller
World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
|
30 |
Long-term potentiation in autonomic ganglia: Potential role in cardiovascular disorders
World J Pharmacol
5(2):51-58.
Published online Jun 9, 2016.
doi: 10.5497/wjp.v5.i2.51
|
31 |
Drug therapy for Parkinson’s disease: An update
World J Pharmacol
4(1):117-143.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.117
|
32 |
Implantable (Bio)sensors as new tools for wireless monitoring of brain neurochemistry in real time
Donatella Farina, Maria D Alvau, Giulia Puggioni, Giammario Calia, Gianfranco Bazzu, Rossana Migheli, Ottavio Sechi, Gaia Rocchitta, Maria S Desole, Pier Andrea Serra
World J Pharmacol
3(1):1-17.
Published online Mar 9, 2014.
doi: 10.5497/wjp.v3.i1.1
|
33 |
Pharmacological management of neuropathic pain in patients with vestibular schwannomas: Experience of the Atlantic Lateral Skull Base Clinic
Andrea LO Hebb, Jana Sawynok, Manohar Bance, Simon Walling, Ken Chisholm, David P Morris
World J Pharmacol
3(2):24-32.
Published online Jun 9, 2014.
doi: 10.5497/wjp.v3.i2.24
|
34 |
Antimicrobial resistance in clinically important biofilms
Fatemeh Rafii, Mark E Hart
World J Pharmacol
4(1):31-46.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.31
|
35 |
Overview on metabolomics in traditional Chinese medicine
Shi Qiu, Ai-Hua Zhang, Hui Sun, Guang-Li Yan, Xi-Jun Wang
World J Pharmacol
3(3):33-38.
Published online Sep 9, 2014.
doi: 10.5497/wjp.v3.i3.33
|
36 |
Potential ability of xanthophylls to prevent obesity-associated cancer
Masaru Terasaki, Michihiro Mutoh, Gen Fujii, Mami Takahashi, Rikako Ishigamori, Sonoko Masuda
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
|
37 |
Importance of microenvironment in preclinical models of breast and prostate cancer
Maija Valta, Katja Fagerlund, Mari Suominen, Jussi Halleen, Johanna Tuomela
World J Pharmacol
4(1):47-57.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.47
|
38 |
Use of eltrombopag in thrombocytopenia of liver disease
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
|
39 |
Telomerase activity: An attractive target for cancer therapeutics
Lucia Picariello, Cecilia Grappone, Simone Polvani, Andrea Galli
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
|
40 |
Vitamin D and bone fracture healing
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
|
41 |
Aryl hydrocarbon receptor as a new therapeutic target for cancer and immune disorders
Libia Vega, Guillermo Elizondo
World J Pharmacol
2(4):107-114.
Published online Dec 9, 2013.
doi: 10.5497/wjp.v2.i4.107
|
42 |
Progress in pancreatic cancer therapeutics: The potential to exploit molecular targets
Kiruthikah Thillai, Debashis Sarker, Paul Ross
World J Pharmacol
4(2):180-192.
Published online Jun 9, 2015.
doi: 10.5497/wjp.v4.i2.180
|
43 |
Levomilnacipran and vortioxetine: Review of new pharmacotherapies for major depressive disorder
Mei T Liu, Megan E Maroney, Evelyn R Hermes-DeSantis
World J Pharmacol
4(1):17-30.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.17
|
44 |
Utility of transporter/receptor(s) in drug delivery to the eye
Sai HS Boddu, Jerry Nesamony
World J Pharmacol
2(1):1-17.
Published online Mar 9, 2013.
doi: 10.5497/wjp.v2.i1.1
|
45 |
Improving cancer therapy by targeting cancer stem cells: Directions, challenges, and clinical results
Pier Adelchi Ruffini, Valentina Vaja, Marcello Allegretti
World J Pharmacol
4(1):58-74.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.58
|
46 |
Arsenic exposure decreases rhythmic contractions of vascular tone through sodium transporters and K + channels
Javier Palacios, Chukwuemeka R Nwokocha, Fredi Cifuentes
World J Pharmacol
3(2):18-23.
Published online Jun 9, 2014.
doi: 10.5497/wjp.v3.i2.18
|
47 |
Advances in the treatment of nonalcoholic steatohepatitis
World J Pharmacol
9(1):1-12.
Published online Oct 28, 2020.
doi: 10.5497/wjp.v9.i1.1
|
48 |
Challenges and opportunities in the treatment of ulcerative colitis
Sunil Ashokrao Nirmal, Sunil Shivaji Gangurde, Pratiksha Shankar Dumbre, Subodh Chandra Pal, Subhash Chandra Mandal
World J Pharmacol
4(2):219-226.
Published online Jun 9, 2015.
doi: 10.5497/wjp.v4.i2.219
|
49 |
Pharmacological role of efflux transporters: Clinical implications for medication use during breastfeeding
Hilai Ahmadzai, Lisa BG Tee, Andrew Crowe
World J Pharmacol
3(4):153-161.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.153
|
50 |
Protective effect of fu-qi granule on carbon tetrachloride-induced liver fibrosis in rats
Lin Zhong, Yan-Ling Sun, Wen-Li Shi, Xiao Ma, Zhe Chen, Jia-Bo Wang, Rui-Sheng Li, Xue-Ai Song, Hong-Hong Liu, Yan-Ling Zhao, Xiao-He Xiao
World J Pharmacol
4(2):227-235.
Published online Jun 9, 2015.
doi: 10.5497/wjp.v4.i2.227
|